A Phase II Study of Gemcitabine, Vincristine, and Cisplatin As Second-Line Treatment for Patients With Advanced Soft Tissue Sarcoma | |
Luo, Zhiguo; Zhang, Xiaowei; Peng, Wei; Wu, Xianghua; Wang, Huijie; Yu, Hui; Wang, Jialei; Chang, Jianhua; Hong, Xiaonan | |
刊名 | MEDICINE
![]() |
2015 | |
卷号 | 94期号:43 |
ISSN号 | 0025-7974 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4875926 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Luo, Zhiguo,Zhang, Xiaowei,Peng, Wei,et al. A Phase II Study of Gemcitabine, Vincristine, and Cisplatin As Second-Line Treatment for Patients With Advanced Soft Tissue Sarcoma[J]. MEDICINE,2015,94(43). |
APA | Luo, Zhiguo.,Zhang, Xiaowei.,Peng, Wei.,Wu, Xianghua.,Wang, Huijie.,...&Hong, Xiaonan.(2015).A Phase II Study of Gemcitabine, Vincristine, and Cisplatin As Second-Line Treatment for Patients With Advanced Soft Tissue Sarcoma.MEDICINE,94(43). |
MLA | Luo, Zhiguo,et al."A Phase II Study of Gemcitabine, Vincristine, and Cisplatin As Second-Line Treatment for Patients With Advanced Soft Tissue Sarcoma".MEDICINE 94.43(2015). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论